SCHEMBL7751195

SCHEMBL7751195

Cc1cc2c(NC3CCC(O)CC3)nc(-c3ccccc3)nc2[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 3/20 0.67
▸ ADORA2A P29274 2/20 0.67
▸ ADORA3 P0DMS8 1/20 0.67
▸ ADORA2B P29275 1/20 0.67
▸ ACP1 P24666 3/20 0.54
▸ PDE5A O76074 2/20 0.49
▸ CYP1A2 P05177 7/20 0.47
▸ CYP3A4 P08684 6/20 0.47
▸ CLK4 Q9HAZ1 6/20 0.47
▸ USP2 O75604 4/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ TSHR P16473 3/20 0.47
▸ MAPK1 P28482 3/20 0.47
▸ CYP2D6 P10635 3/20 0.47
▸ CYP2C19 P33261 3/20 0.47
▸ TP53 P04637 3/20 0.47
▸ ALOX15 P16050 3/20 0.47
▸ KMT2A Q03164 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22587416 0.94 ACP1 (0.60) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL22587506 0.89 ACP1 (0.62) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL22587451 0.88 ACP1 (0.63) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL7751012 0.84 ADORA1 (0.62) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL22587448 0.84 ADORA1 (0.46) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL4079175 0.84 ADORA1 (0.65) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL7751035 0.84 ADORA1 (0.65) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL22587476 0.84 ADORA1 (0.47) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL22587503 0.83 CYP1A2 (0.48) ADORA1ADORA2AADORA3ADORA2BACP1
SCHEMBL22587470 0.83 HRH4 (0.47) ADORA1ADORA2AADORA3ADORA2BACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598252-B2 Compounds specific to adenosine A, receptors and uses thereof OSI PHARMACEUTICALS, INC. (US) 2009-10-06 — — US disclosed
EP-2011499-A2 Pyrrolo[2,3d]Pyrimidine compositions and their use OSI Pharmaceuticals, Inc. (US) 2009-01-07 — — EP disclosed
US-7429574-B2 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use OSI PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
US-7429574-B2 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use OSI PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
US-20080070936-A1 Compounds specific to adenosine A1 receptors and uses thereof OSI PHARMACEUTICALS, INC. 2008-03-20 — — US disclosed
US-20080070936-A1 Compounds specific to adenosine A1 receptors and uses thereof OSI PHARMACEUTICALS, INC. 2008-03-20 — — US disclosed
US-6680324-B2 4-AMINO-6-PHENYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2004-01-20 — — US disclosed
US-6680324-B2 4-AMINO-6-PHENYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2004-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070936-A1 Compounds specific to adenosine A1 receptors and uses thereof ADORA1, ADORA2A, ADORA3 ADORA1 1/4885ADORA2A 2/4885ADORA3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback